
Reduced Vancomycin Susceptibility, MRSA and Treatment Failure in Pediatric Staphylococcus aureus Bloodstream Infections
Author(s) -
Ethan Canty,
Benjamin Carnahan,
Tara Curley,
Emily Anususinha,
Rana F. Hamdy,
Jessica E. Ericson
Publication year - 2020
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000002992
Subject(s) - medicine , vancomycin , bacteremia , odds ratio , methicillin resistant staphylococcus aureus , staphylococcus aureus , confidence interval , antibiotics , staphylococcal infections , microbiology and biotechnology , biology , bacteria , genetics
Clinical implications of reduced vancomycin susceptibility (RVS) among pediatric Staphylococcus aureus bloodstream infections are unknown.